When the VentureClash challenge was launched in April 2016, organisers received applications from nearly 200 worldwide early-stage companies. Back in September, only 10 startups were shortlisted and invited to Yale University on October 20, 2016 to compete for the investment prize.LindaCare was one of them and was awarded the third place by the panel of judges.
Headquartered in Brussels, the digital health software company specializing in the field of remote monitoring solutions for chronic disease patients, brought back home a $500,000 investment and will benefit from additional mentorship and support from Connecticut Innovations to accelerate its US market expansion plans.
Companies were judged based on their innovative technology,scalable business model, skilled management team, market validation, solid traction and US expansion plans. Shahram Sharif, CEO and founder of LindaCare, highlighted that "this recognition is the first and foremost strong, positive feedback for LindaCare’s team efforts and achievements. It also confirms that our value proposition perfectly fits the US market and has the potential to significantly help the healthcare system with better management of patients with chronic diseases – notably heart diseases – through remote patient monitoring".
As for what's coming up next for the healtech startup, Sharif added: "this investment award, coupled with the additional mentorship and support from Connecticut Innovations, will accelerate our US market expansion plans in the very near future".
Lindacare is a startup venture-capital backed by Capricorn ICT Fund, specialised in the development of integrated remote monitoring software solutions for chronic disease management. The initial focus of LindaCare are patients with heart failure (HF) and cardiac arrhythmia, equipped with Cardiac Implanted Electronic Devices (CIED) for Cardiac Rhythm Management (CRM). The solution will subsequently be extended to other chronic disease domains integrating a wide range of tele-monitored medical devices.